Cited by 183Chronic Obstructive Pulmonary Disease (COPD) ResearchChemokine receptors and signalingAsthma and respiratory diseases

SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects

Open access
Holz, O., Khalilieh, S., Ludwig-Sengpiel, A., Watz, H., Stryszak, P., Soni, P., Tsai, M., Sadeh, J. +1 more·2010·European Respiratory Journal

Abstract

SCH527123 is a novel, selective CXC chemokine receptor 2 antagonist that inhibits neutrophil activation and modulates neutrophil trafficking in animal models, characteristics that may be beneficial in the treatment of conditions with unbalanced pulmonary neutrophilia, such as chronic obstructive pulmonary disease. The purpose of this proof-of-principle study was to determine whether SCH527123 inhibits ozone-induced neutrophil recruitment in healthy humans. In a randomised, double-blind, placebo-controlled, three-way crossover study, oral SCH527123 (50 mg once daily, 4 days), prednisolone (50 mg once), or placebo was alternated with 2-week washouts. 18 healthy ozone responders (>20% increase in sputum neutrophils) underwent ozone challenge tests (250 ppb, 3 h intermittent exercise) 1 h after the last treatment dose. Sputum was induced at 3 h post-challenge. After SCH527123 treatment, the ozone challenge resulted in significantly lower sputum neutrophil counts (0.13x10(6).mL(-1)) compared with prednisolone (0.84x10(6).mL(-1); p<0.001) or placebo (2.98x10(6).mL(-1); p<0.001). Comparable results were obtained for total cell count, percentage of sputum neutrophils, and for interleukin-8 and myeloperoxidase in sputum supernatant. Post-challenge, SCH527123 inhibited neutrophilia in peripheral blood but significantly less than in sputum. All treatments were safe and well tolerated. SCH527123 causes significant attenuation of ozone-induced airway neutrophilia in healthy subjects. Further evaluation in a large trial of patients with pulmonary disorders is warranted.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00048509

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ozone exposure resulted in significant neutrophilic inflammation, reflected with increased levels of myeloperoxidase in the supernatant of induced sputum samples from healthy subjects.

    “Ozone exposure resulted in significant neutrophilic inflammation, reflected with increased levels of myeloperoxidase (MPO) in the supernatant of induced sputum samples from healthy subjects (39, 40).”

    From Ozone pollution: A Major health hazard worldwide (2019) · cites this paper as [40]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Holz, O., Khalilieh, S., Ludwig-Sengpiel, A., Watz, H., Stryszak, P., Soni, P., Tsai, M., Sadeh, J., & Magnussen, H.
Affiliations
LungenClinic Grosshansdorf (DE)
Corresponding author
Magnussen, H.
Venue
European Respiratory Journal
Published
2009-07-30
Volume
35
Issue
3
Pages
564-570
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2037542404
Cited by
183
References
31
Citations by year
2026: 2 · 2025: 6 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 3 · 2018: 8 · 2017: 13 · 2016: 12 · 2015: 31 · 2014: 15 · 2013: 25 · 2012: 24
FWCI
10.70
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
Keywords
CXCR2 antagonist, airway neutrophilia, sputum neutrophils, neutrophil recruitment, interleukin-8, myeloperoxidase, prednisolone, chronic obstructive pulmonary disease, airway inflammation
MeSH terms
Adult, Benzamides, Cyclobutanes, Double-Blind Method, Female, Humans, Leukocyte Count, Lung, Male, Middle Aged, Peroxidase, Neutrophils, Sputum, Interleukin-8, Cross-Over Studies, Neutrophil Infiltration, Receptors, Interleukin-8B, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review